Primary Biliary Cholangitis Treatment Market Analysis to Grow at Highest Pace owing to Increasing Disease Prevalence
Primary biliary cholangitis (PBC) refers to a chronic autoimmune disease that damages small bile ducts in the liver. The symptoms of PBC include fatigue, itching, jaundice and abdominal pain. Traditional treatment options include ursodeoxycholic acid (UDCA) and liver transplantation.Key players operating in the Primary Biliary Cholangitis Treatment Market Analysis are Intercept Pharmaceuticals, Inc., Highlight Therapeutics, S.L., GSK. Intercept Pharmaceuticals commercializes obeticholic acid (Ocaliva) for treating PBC.

Primary Biliary Cholangitis Treatment Market

https://www.coherentmarket...

#Primary Biliary Cholangitis Treatment Market
Analysis,#Primary Biliary Cholangitis, #PBC Treatment,
#Autoimmune Diseases,#Liver Health, #pharmaceutical Market, #Coherent market insights.